Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

49.0K
Overview
49.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Otolith dysfunction in recurrent benign paroxysmal positional vertigo after mild traumatic brain injury.

Acta oto-laryngologica·2019
Same author

Dark Current Reduction Strategy via a Layer-By-Layer Solution Process for a High-Performance All-Polymer Photodetector.

ACS applied materials & interfaces·2019
Same author

Combination of ozonation and electrolysis process to enhance elimination of thirty structurally diverse pharmaceuticals in aqueous solution.

Journal of hazardous materials·2019
Same author

Long noncoding RNA <i>ANRIL</i> regulates endothelial cell activities associated with coronary artery disease by up-regulating <i>CLIP1</i>, <i>EZR</i>, and <i>LYVE1</i> genes.

The Journal of biological chemistry·2019
Same author

Degradation of Ofloxacin by Perylene Diimide Supramolecular Nanofiber Sunlight-Driven Photocatalysis.

Environmental science & technology·2019
Same author

Gene expression profiling reveals differential patterns between microcystic congenital cystic adenomatoid malformation and congenital lobar emphysema.

Early human development·2018

Related Experiment Video

Updated: Sep 20, 2025

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.9K

RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.

Lei Zhang1, Shi Tang1, Yue Ma1

  • 1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Frontiers in Immunology
|June 6, 2022
PubMed
Summary

Repulsive guidance molecule-a (RGMa) disrupts the blood-brain barrier (BBB) in multiple sclerosis (MS) by activating the BMP2/BMPR II/YAP pathway, offering a new therapeutic target for MS.

Keywords:
blood–brain barrierbone morphogenetic proteinmultiple sclerosisrepulsive guidance molecule-ayes-associated protein

More Related Videos

Author Spotlight: Insight Into Advances in Prion Diseases Research
10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

581
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

1.1K

Related Experiment Videos

Last Updated: Sep 20, 2025

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

7.9K
Author Spotlight: Insight Into Advances in Prion Diseases Research
10:40

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

581
Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research
04:43

Author Spotlight: Insights and Innovations in Gene Expression Manipulation Techniques for Choroid Plexus Research

Published on: June 16, 2023

1.1K

Area of Science:

  • Neuroimmunology
  • Vascular Biology
  • Cellular Signaling

Background:

  • The blood-brain barrier (BBB) dysfunction is critical in multiple sclerosis (MS) pathogenesis, but underlying mechanisms remain unclear.
  • Repulsive guidance molecule-a (RGMa) is implicated in MS, yet its precise role in BBB integrity requires further investigation.

Purpose of the Study:

  • To investigate RGMa's role in regulating BBB permeability in endothelial cells and MS.
  • To elucidate the molecular mechanisms by which RGMa influences BBB integrity.

Main Methods:

  • Established an experimental autoimmune encephalomyelitis (EAE) mouse model and human brain microvascular endothelial cell (HBMEC) cultures.
  • Assessed BBB permeability via RGMa overexpression and knockdown, and analyzed signaling pathways involving BMP2/BMPRII and YAP.
  • Measured RGMa levels in MS patients with and without contrast-enhancing lesions.

Main Results:

  • RGMa, BMP2/BMPRII, and YAP expression correlated with BBB disruption in EAE mice and HBMECs.
  • RGMa overexpression increased BBB permeability, while RGMa knockdown enhanced BBB integrity in vitro.
  • RGMa-induced BBB dysfunction involves the BMP2/BMPRII/YAP pathway, leading to decreased tight junction proteins (ZO-1, claudin-5).
  • Elevated serum RGMa levels were observed in MS patients, particularly those with active lesions.

Conclusions:

  • RGMa drives BBB dysfunction in MS via the BMP2/BMPRII/YAP signaling cascade.
  • RGMa represents a potential therapeutic target for managing BBB permeability in multiple sclerosis.